[心力衰竭患者的平板-正极症综合征:一个病例报告]
Muriel Gauthier1, Nicolas-Charles Roche1, Thomas Audoual1
1Service de pathologies cardiovasculaires, hôpital d'instruction des armées Laveran, 34, boulevard Laveran, CS 50004, 13384 Marseille, France.
概括
平板呼吸缺氧综合征,通常是由圆孔 (PFO) 引起的,呈现为位置性呼吸障碍. 穿皮式PFO关闭有效地解决了老年患者的症状,突出了其治疗价值.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 平板呼吸正氧综合征 (POS) 是一种罕见的疾病,其特征是位置性呼吸不良和氧气不和.
- 最常见的POS原因是圆孔 (PFO) 导致右至左心内道.
- 严重的POS可能会导致显著的功能障碍和与低血相关的死亡率.
研究的目的:
- 在老年患者中报告POS病例.
- 为了证明穿皮专利孔圆形关闭在治疗POS时的有效性.
- 强调考虑PFO关闭在老年POS患者中的重要性.
主要方法:
- 一名93岁的急性心力衰竭患者出现了复发的位置性呼吸不良和脱.
- 通过食管回声心电图与泡研究确定了一条通过PFO的大型右至左分流.
- 进行了PFO的穿皮关闭.
主要成果:
- 患者在PFO关闭后经历了POS症状的完全消失.
- 长期的氧气治疗在手术后被停止.
- 这项干预导致了显著的临床改善.
结论:
- 与PFO相关的POS经常被诊断为晚期.
- 高龄和并发症不应该成为皮肤穿透PFO关闭的障碍.
- 穿皮式PFO关闭为POS患者提供了大量的临床益处.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
172
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
172
Acute Respiratory Failure-IV
126
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
126
Hyperpnea and Hyperventilation
977
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
977
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174


